First Missense Mutation in the SOST Gene Causing Sclerosteosis by Loss of Sclerostin Function

被引:63
|
作者
Piters, Elke [1 ]
Culha, Cavit [2 ]
Moester, Martiene [3 ]
Van Bezooijen, Rutger [3 ]
Adriaensen, Dirk [4 ]
Mueller, Thomas [5 ]
Weidauer, Stella [5 ]
Jennes, Karen [1 ]
De Freitas, Fenna [1 ]
Lowik, Clemens [3 ]
Timmermans, Jean-Pierre [4 ]
Van Hul, Wim [1 ]
Papapoulos, Socrates [3 ]
机构
[1] Univ Antwerp, Dept Med Genet, B-2650 Edegem, Belgium
[2] Ankara Numune Training & Res Hosp, Dept Endocrinol & Metab, Ankara, Turkey
[3] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands
[4] Univ Antwerp, Lab Cell Biol & Histol, B-2650 Edegem, Belgium
[5] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, D-97070 Wurzburg, Germany
关键词
SOST; sclerostin; Wnt signaling; sclerosteosis; VAN-BUCHEM-DISEASE; DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; CHROMOSOME; 17Q12-Q21; MINERAL DENSITY; LRP5; MUTATIONS; BMP ANTAGONIST; HUMAN LYSOZYME; SECRETION; PROTEIN;
D O I
10.1002/humu.21274
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sclerosteosis is a rare bone dysplasia characterized by greatly increased bone mass, especially of the long bones and the skull. Patients are tall, show facial asymmetry and often have syndactyly. Clinical complications are due to entrapment of cranial nerves. The disease is thought to be due to loss-of-function mutations in the SOST gene. The SOST gene product, sclerostin, is secreted by osteocytes and transported to the bone surface where it inhibits osteoblastic bone formation by antagonizing Wnt signaling. In a small Turkish family with sclerosteosis, we identified a missense mutation (c.499T>C; p.Cys167Arg) in exon 2 of the SOST gene. This type of mutation has not been previously reported and using different functional approaches, we show that it has a devastating effect on the biological function of sclerostin. The affected cysteine is the last cysteine residue of the cystine-knot motif and loss of this residue leads to retention of the mutant protein in the ER, possibly as a consequence of impaired folding. Together with a significant reduced ability to bind to LRP5 and inhibit Wnt signaling, the p.Cys167Arg mutation leads to a complete loss of function of sclerostin and thus to the characteristic sclerosteosis phenotype. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:E1526 / E1543
页数:18
相关论文
共 50 条
  • [1] A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis
    Fayez, Alaaeldin
    Aglan, Mona
    Esmaiel, Nora
    El Zanaty, Taher
    Kader, Mohamed Abdel
    El Ruby, Mona
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [2] Novel SOST gene mutation in a sclerosteosis patient and her parents
    Bhadada, Sanjay Kumar
    Rastogi, Ashu
    Steenackers, Ellen
    Boudin, Eveline
    Arya, Ashutosh
    Dhiman, Vandana
    Bhansali, Anil
    Van Hul, Wim
    BONE, 2013, 52 (02) : 707 - 710
  • [3] Sclerostin, the protein product of the sclerosteosis gene (SOST) and a key regulator of bone matrix formation, binds to BMPs and antagonizes their function.
    Winkler, DG
    Hayes, T
    Geoghegan, J
    Skonier, J
    Ursino, R
    Sutherland, MK
    Latham, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S322 - S322
  • [4] Novel SOST gene mutation in a sclerosteosis patient from Morocco: A case report
    Belkhribchia, Mohamed Reda
    Collet, Corinne
    Laplanche, Jean-Louis
    Hassani, Redouane
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2014, 57 (04) : 133 - 137
  • [5] A Known SOST Gene Mutation Causes Sclerosteosis in a Familial and an Isolated Case from Brazilian Origin
    Kim, Chong Ae
    Honjo, Rachel
    Bertola, Debora
    Albano, Lilian
    Oliveira, Luiz
    Jales, Sumatra
    Siqueira, Jose
    Castilho, Arthur
    Balemans, Wendy
    Piters, Elke
    Jennes, Karen
    Van Hul, Wim
    GENETIC TESTING, 2008, 12 (04): : 475 - 479
  • [6] Gene dose effect of a SOST mutation on circulating sclerostin and P1NP
    Van Lierop, A.
    Hamersma, H.
    Hamdy, N.
    Papapoulos, S.
    BONE, 2011, 48 : S85 - S85
  • [7] Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
    Brunkow, ME
    Gardner, JC
    Van Ness, J
    Paeper, BW
    Kovacevich, BR
    Proll, S
    Skonier, JE
    Zhao, L
    Sabo, PJ
    Fu, YH
    Alisch, RS
    Gillett, L
    Colbert, T
    Tacconi, P
    Galas, D
    Hamersma, H
    Beighton, P
    Mulligan, JT
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) : 577 - 589
  • [8] Van buchem disease mouse models and genomic comparisons reveal a bone-specific enhancer regulating sclerosteosis causing gene SOST.
    Kneissel, M
    Keller, HJ
    Baptist, M
    Rubin, EM
    Loots, GG
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S21 - S21
  • [9] A novel missense mutation in the FGFR3 gene causing hypochondroplasia
    Heuertz, S
    Le Merrer, M
    Cormier-Daire, V
    Legeai-Mallet, L
    Flori, E
    Munnich, A
    Bonaventure, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 262 - 262
  • [10] Identification of a novel loss-of-function missense mutation in the RANKL gene that causes osteopetrosis in mice
    Douni, E.
    Makrinou, E.
    Kollias, G.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S57 - S57